It’s not only who we are but also what we want to achieve.

Patients with neurological disorders need an accurate, early diagnosis for better quality of life for them and their families/caregivers. We aim to continue to innovate new ways to support clinicians in providing the best care for their patients.
With a long, collective history of science and research, we combine our knowledge of neurological conditions, passion for innovative technology like artificial intelligence, and insights from our partnerships with clinical care centers to develop new solutions that fill the gaps in clinical care.
When we hear from current customers that cNeuro has provided the information they need for confident, evidence-based decisions for their patients, we know that we’re on the right track. Yet, we are constantly looking forward to addressing the next challenge, whether that’s aiding with patient selection for clinical trials of disease-modifying drugs for Alzheimer’s disease or putting tools directly in the hands of patients.
Based in Finland, we take pride in our Nordic background and close relationships with leading institutions in the area as well as in the international community.

It’s not only who we are but also what we want to achieve.

Patients with neurological disorders need an accurate, early diagnosis for better quality of life for them and their families/caregivers. We aim to continue to innovate new ways to support clinicians in providing the best care for their patients.
With a long, collective history of science and research, we combine our knowledge of neurological conditions, passion for innovative technology like artificial intelligence, and insights from our partnerships with clinical care centers to develop new solutions that fill the gaps in clinical care.
When we hear from current customers that cNeuro has provided the information they need for confident, evidence-based decisions for their patients, we know that we’re on the right track. Yet, we are constantly looking forward to addressing the next challenge, whether that’s aiding with patient selection for clinical trials of disease-modifying drugs for Alzheimer’s disease or putting tools directly in the hands of patients.
Based in Finland, we take pride in our Nordic background and close relationships with leading institutions in the area as well as in the international community.

Our Leadership

Richard Hausmann
CEO
Lennart Thurfjell
COO
Jyrki Lötjönen

CSO

Jussi Mattila

CTO

Cilla Lundevall
Head of Quality Assurance and Regulatory Affairs

Our Team

Chris Oppelt
Chris Oppelt
US Sales Director
Michel Krambousanos
EU Sales Director
Juha Koikkalainen
Juha Koikkalainen
Sr. Imaging Scientist
Antti Tolonen
Antti Tolonen

Sr. Imaging Scientist

Jin Gong
Jin Gong
Imaging Scientist
Markus Niiranen
Markus Niiranen
Sr. Software Developer
Samuel Lahtinen
Samuel Lahtinen
Sr. Software Developer
Usman Iftikhar
Usman Iftikhar

Sr. Software Developer

Daniil Zhitnitskii
Daniil Zhitnitskii
Software Developer

Our Medical Advisors

Miia Kivipelto
Frederik Barkhof